{"id":"https://openalex.org/W2249449600","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.7507","title":"Efficacy and safety of axitinib (AG-013736; AG) in patients (pts) with advanced non-small cell lung cancer (NSCLC): A phase II trial","display_name":"Efficacy and safety of axitinib (AG-013736; AG) in patients (pts) with advanced non-small cell lung cancer (NSCLC): A phase II trial","publication_year":2007,"publication_date":"2007-06-20","ids":{"openalex":"https://openalex.org/W2249449600","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.7507","mag":"2249449600"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2007.25.18_suppl.7507","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.7507","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.7507","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050185260","display_name":"Joan H. Schiller","orcid":"https://orcid.org/0000-0003-0990-1211","observed_orcids":["https://orcid.org/0000-0003-0990-1211"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. H. Schiller","raw_affiliation_strings":["University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT","institution_ids":["https://openalex.org/I180857899","https://openalex.org/I4210087865","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006506843","display_name":"Timothy G. Larson","orcid":"https://orcid.org/0009-0001-8921-6857","observed_orcids":["https://orcid.org/0009-0001-8921-6857"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Larson","raw_affiliation_strings":["University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT","institution_ids":["https://openalex.org/I180857899","https://openalex.org/I4210087865","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025150511","display_name":"S. Ou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. I. Ou","raw_affiliation_strings":["University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT","institution_ids":["https://openalex.org/I180857899","https://openalex.org/I4210087865","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048571413","display_name":"Steven A. Limentani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. A. Limentani","raw_affiliation_strings":["University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT","institution_ids":["https://openalex.org/I180857899","https://openalex.org/I4210087865","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078389632","display_name":"Alan B. Sandler","orcid":"https://orcid.org/0009-0004-5397-5247","observed_orcids":["https://orcid.org/0009-0004-5397-5247"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. B. Sandler","raw_affiliation_strings":["University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT","institution_ids":["https://openalex.org/I180857899","https://openalex.org/I4210087865","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063904421","display_name":"Everett E. Vokes","orcid":"https://orcid.org/0000-0002-8645-8068","observed_orcids":["https://orcid.org/0000-0002-8645-8068"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. E. Vokes","raw_affiliation_strings":["University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT","institution_ids":["https://openalex.org/I180857899","https://openalex.org/I4210087865","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028773499","display_name":"S. Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Kim","raw_affiliation_strings":["University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT","institution_ids":["https://openalex.org/I180857899","https://openalex.org/I4210087865","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091509242","display_name":"Katherine Liau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. F. Liau","raw_affiliation_strings":["University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT","institution_ids":["https://openalex.org/I180857899","https://openalex.org/I4210087865","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025882028","display_name":"Paul W. Bycott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. W. Bycott","raw_affiliation_strings":["University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT","institution_ids":["https://openalex.org/I180857899","https://openalex.org/I4210087865","https://openalex.org/I4390039299"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076736008","display_name":"Anthony J. Olszanski","orcid":"https://orcid.org/0000-0001-5276-5898","observed_orcids":["https://orcid.org/0000-0001-5276-5898"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. J. Olszanski","raw_affiliation_strings":["University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern, Dallas, TX; Hubert H. Humphrey Cancer Centre, Robinsdale, MN; Chao Family Comprehensive Cancer Centre, Orange, CA; Carolinas Hematology-Oncology, Charlotte, NC; Vanderbilt-Ingram Cancer Centre, Nashville, TN; University of Chicago Medical Center, Chicago, IL; Pfizer, Inc., San Diego, CA; Pfizer, Inc., New London, CT","institution_ids":["https://openalex.org/I180857899","https://openalex.org/I4210087865","https://openalex.org/I4390039299"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":41,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"18_suppl","first_page":"7507","last_page":"7507"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9648000001907349,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9648000001907349,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.022600000724196434,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/axitinib","display_name":"axitinib","score":0.8560000061988831},{"id":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer","display_name":"advanced non-small cell lung cancer","score":0.871999979019165},{"id":"https://openalex.org/keywords/vegfr-tyrosine-kinase-inhibitors","display_name":"VEGFR inhibitors","score":0.7509999871253967},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8700000047683716},{"id":"https://openalex.org/keywords/pdgfrbeta","display_name":"PDGFR\u03b2","score":0.7210000157356262},{"id":"https://openalex.org/keywords/kit","display_name":"KIT","score":0.9440000057220459},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.6919999718666077},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9190000295639038},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.7049999833106995},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.753000020980835},{"id":"https://openalex.org/keywords/hyponatremia","display_name":"hyponatremia","score":0.7990000247955322},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7789999842643738},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.6759999990463257},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.9520000219345093},{"id":"https://openalex.org/keywords/metastatic-nsclc","display_name":"metastatic non-small cell lung cancer","score":0.7730000019073486},{"id":"https://openalex.org/keywords/stage-iiib-nsclc","display_name":"stage IIIB NSCLC","score":0.8790000081062317}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9193331003189087},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6942707300186157},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.557164192199707},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.466645747423172},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.45923149585723877},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.4507862329483032},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4426647424697876},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4266740679740906},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.41885221004486084},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3784377872943878},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.33047038316726685}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2007.25.18_suppl.7507","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.7507","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.7507","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2052239818","https://openalex.org/W1992397660","https://openalex.org/W2169976781","https://openalex.org/W107714126","https://openalex.org/W2072020463","https://openalex.org/W2566159668","https://openalex.org/W2012039821","https://openalex.org/W3095369806","https://openalex.org/W3005259070","https://openalex.org/W2102996502"],"abstract_inverted_index":{"7507":[0],"Background:":[1],"A":[2,94,131],"correlation":[3],"between":[4],"vascular":[5],"endothelial":[6],"growth":[7],"factor":[8],"(VEGF),":[9],"microvessel":[10],"density,":[11],"and":[12,39,41,46,59,86,152,175,221,253,271],"prognosis":[13],"has":[14],"been":[15],"reported":[16,193],"in":[17,63,104,112,280,292,297],"pts":[18,64,103,118,135,235,242,247,281],"with":[19,32,65,70,101,194,282,289],"NSCLC.":[20,67,284],"AG":[21,62,77,275],"is":[22,49,286,300],"a":[23,195],"small":[24],"molecule":[25],"inhibitor":[26],"of":[27,61,90,133,181,200,205,239,255],"the":[28,57,105,113],"receptor":[29],"tyrosine":[30],"kinases,":[31],"picomolar":[33],"potency":[34,43],"against":[35,44],"VEGFR":[36],"1,":[37],"2":[38],"3":[40],"nanomolar":[42],"PDGFR-\u03b2":[45],"KIT.":[47],"This":[48],"an":[50,109],"open-label,":[51],"multicenter":[52],"phase":[53],"II":[54],"study":[55],"examining":[56],"efficacy":[58,240],"safety":[60],"advanced":[66,283],"Methods:":[68],"Pts":[69],"stage":[71,107,115],"IIIB":[72],"or":[73,92],"metastatic":[74],"NSCLC":[75],"received":[76,161],"5":[78,246],"mg":[79],"BID.":[80],"Eligibility":[81],"criteria":[82],"included":[83],"measurable":[84],"disease":[85],"ECOG":[87],"performance":[88],"status":[89],"0":[91],"1.":[93],"Simon":[95],"2-stage":[96],"minimax":[97],"design":[98],"was":[99,123,140,183,207,213,224],"used":[100],"18":[102],"first":[106],"plus":[108],"additional":[110],"14":[111],"second":[114],"if":[116],"1/18":[117],"responded.":[119],"The":[120],"primary":[121],"endpoint":[122],"response":[124,206],"rate":[125],"(RR)":[126],"according":[127],"to":[128],"RECIST.":[129],"Results:":[130],"total":[132],"32":[134],"were":[136,145,177,192,264],"enrolled:":[137],"median":[138],"age":[139],"66":[141],"yrs":[142],"(39\u201380);":[143],"histologies":[144],"adenocarcinoma":[146],"(75%),":[147],"squamous":[148],"cell":[149],"carcinoma":[150],"(9%),":[151],"not":[153],"otherwise":[154],"specified":[155],"(16%);":[156],"56%":[157],"male/44%":[158],"female;":[159],"72%":[160],"prior":[162,165,168],"chemotherapy,":[163],"47%":[164,167],"surgery,":[166],"radiotherapy,":[169],"9%":[170],"investigational":[171],"therapy,":[172],"3%":[173],"immunotherapy,":[174],"13%":[176],"treatment-na\u00efve.":[178],"Mean":[179],"duration":[180,204],"treatment":[182],"93":[184],"days":[185],"(1\u2013271).":[186],"Three":[187],"(9.4%)":[188],"investigator":[189],"confirmed":[190],"responses":[191],"95%":[196],"confidence":[197],"interval":[198],"(CI)":[199],"2,":[201],"25.":[202],"Median":[203,211],"9.4":[208],"months":[209],"(mo).":[210],"survival":[212,223],"12.8":[214],"mo":[215,226],"(95%":[216,227],"CI:":[217,228],"9.9":[218],"mo,":[219,230],"undefined)":[220],"progression-free":[222],"5.8":[225],"3.8":[229],"10.2":[231],"mo).":[232],"26":[233],"(81%)":[234],"discontinued":[236],"treatment:":[237],"lack":[238],"19":[241],"(59%),":[243],"adverse":[244],"events":[245],"(16%),":[248],"death":[249],"1":[250,257],"pt":[251,258],"(3%),":[252],"withdrawal":[254],"consent":[256],"(3%).":[259],"Grade":[260],"3/4":[261],"toxicities":[262],"(=5%)":[263],"fatigue":[265],"(22%),":[266],"diarrhea":[267],"(6%),":[268],"hypertension":[269],"(6%)":[270],"hyponatremia":[272],"(6%).":[273],"Conclusions:":[274],"demonstrates":[276],"single-":[277],"agent":[278],"activity":[279],"Therapy":[285],"well":[287],"tolerated":[288],"manageable":[290],"toxicity":[291],"this":[293,298],"population.":[294],"Further":[295],"investigation":[296],"setting":[299],"warranted.":[301],"[Table:":[302],"see":[303],"text]":[304]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}